Rockwell Medical, Inc. SEC filings RMTI
Rockwell Medical, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 29, 2009. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 21, 2024 | — |
| CORRESP | Letter to the SEC | Oct 17, 2024 | — |
| CORRESP | Letter to the SEC | Oct 17, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 15, 2024 | — |
| EFFECT | Filing | Aug 22, 2023 | — |
| CORRESP | Letter to the SEC | Aug 21, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2023 | — |
| EFFECT | Filing | Jul 22, 2022 | — |
| CORRESP | Letter to the SEC | Jul 20, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2022 | — |
| EFFECT | Filing | Jul 5, 2022 | — |
| CORRESP | Letter to the SEC | Jun 30, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2022 | — |
| NT 10-K | Filing | Apr 1, 2022 | Dec 31, 2021 |
| EFFECT | Filing | Oct 8, 2021 | — |
| CORRESP | Letter to the SEC | Oct 6, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 5, 2021 | — |
| NT 10-K | Filing | Mar 17, 2020 | Mar 16, 2020 |
| 8-A12G/A | Filing | Aug 30, 2019 | — |
| EFFECT | Filing | Dec 3, 2018 | — |
| CORRESP | Letter to the SEC | Nov 30, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2018 | — |
| CT ORDER | Filing | Nov 20, 2018 | — |
| D | Filing | Oct 30, 2018 | — |
| EFFECT | Filing | Oct 1, 2018 | — |
| CORRESP | Letter to the SEC | Sep 26, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2018 | — |
| NT 10-Q | Filing | Aug 9, 2018 | Jun 30, 2018 |
| CT ORDER | Filing | Aug 30, 2017 | — |
| CORRESP | Letter to the SEC | Jun 2, 2017 | — |
| DFAN14A | Filing | Jun 1, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 1, 2017 | — |
| DFAN14A | Filing | May 26, 2017 | — |
| DFAN14A | Filing | May 25, 2017 | — |
| DFAN14A | Filing | May 24, 2017 | — |
| CORRESP | Letter to the SEC | May 22, 2017 | — |
| DFAN14A | Filing | May 22, 2017 | — |
| DFAN14A | Filing | May 19, 2017 | — |
| DFAN14A | Filing | May 18, 2017 | — |
| DFAN14A | Filing | May 17, 2017 | — |
| UPLOAD | Letter from the SEC | May 17, 2017 | — |
| CORRESP | Letter to the SEC | May 15, 2017 | — |
| DFAN14A | Filing | May 15, 2017 | — |
| DFAN14A | Filing | May 12, 2017 | — |
| UPLOAD | Letter from the SEC | May 12, 2017 | — |
| DFAN14A | Filing | May 10, 2017 | — |
| DFAN14A | Filing | May 8, 2017 | — |
| DFAN14A | Filing | May 5, 2017 | — |
| DFAN14A | Filing | May 4, 2017 | — |
| DFAN14A | Filing | Apr 28, 2017 | — |
| DFAN14A | Filing | Apr 24, 2017 | — |
| DFAN14A | Filing | Apr 24, 2017 | — |
| DFAN14A | Filing | Apr 24, 2017 | — |
| DFAN14A | Filing | Apr 21, 2017 | — |
| DEFC14A | Filing | Apr 21, 2017 | — |
| DEFC14A | Filing | Apr 20, 2017 | — |
| PRRN14A | Filing | Apr 17, 2017 | — |
| PRER14A | Filing | Apr 17, 2017 | — |
| PRRN14A | Filing | Apr 12, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2017 | — |
| DFAN14A | Filing | Apr 7, 2017 | — |
| DFAN14A | Filing | Apr 6, 2017 | — |
| PREC14A | Filing | Apr 5, 2017 | — |
| PREC14A | Filing | Apr 3, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 28, 2017 | — |
| DFAN14A | Filing | Mar 22, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2017 | — |
| DFAN14A | Filing | Mar 16, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2017 | — |
| DFAN14A | Filing | Mar 13, 2017 | — |
| DFAN14A | Filing | Mar 10, 2017 | — |
| DFAN14A | Filing | Mar 9, 2017 | — |
| DFAN14A | Filing | Mar 2, 2017 | — |
| EFFECT | Filing | Jun 16, 2015 | — |
| CORRESP | Letter to the SEC | Jun 12, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2015 | — |
| CT ORDER | Filing | Mar 31, 2015 | — |
| D | Filing | Oct 15, 2014 | — |
| CT ORDER | Filing | Dec 9, 2013 | — |
| CT ORDER | Filing | Sep 5, 2013 | — |
| EFFECT | Filing | Jun 13, 2012 | — |
| CORRESP | Letter to the SEC | Jun 12, 2012 | — |
| CORRESP | Letter to the SEC | Jun 11, 2012 | — |
| CORRESP | Letter to the SEC | May 24, 2012 | — |
| UPLOAD | Letter from the SEC | May 10, 2012 | — |
| CT ORDER | Filing | May 31, 2011 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2010 | — |
| CORRESP | Letter to the SEC | Jul 12, 2010 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2010 | — |
Showing 89 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RMTI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wixom, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1041024
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC (until Jun 14, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.